Page 169 - PROGRAMME2018

10:45 O-256
Endometrial proteomic signature in recurrent implantation failure
M. Dogan1, I. Demiral2, E. Akgun3, E. Ulgen4, B. Gurel3, B. Sahin3, A. Nehir Aytan2, B. Yuksel Ozgor2, A.T. Baykal3, U. Sezerman4, E. Bastu1, F. Buyru1
1Acibadem University School of Medicine, Obstetrics and Gynecology, Istanbul, Turkey
2Istanbul University School of Medicine, Obstetrics and Gynecology, Istanbul, Turkey
3Acibadem University School of Medicine, Medical Biochemistry, Istanbul, Turkey
4Acibadem University School of Medicine, Biostatistics and Medical Informatics, Istanbul, Turkey
CRISPR/Cas9 genome editing to reveal the effect of implantation related genes on specific cell types which contribute to implantation process in human and mouse models
G.N. Sahin1, S. Karahuseyinoglu2, A.C. Taskın3
1koc university graduate of medicine, medicine, istanbul, Turkey
2Koç University School Of Medicine, Histology & Embryology, Istanbul, Turkey
3Koç University Research Center for Translational Medicine, Animal Research Facilities, Istanbul, Turkey
T helper 1 cell level is associated with reproductive outcome of women with repeated implantation failures who received Tacrolimus treatment
K. Nakagawa1, J. Kwak-KIm2, A. Moriyama1, K. Nakao1, R. Sugiyama1, T. Horikawa1, S. Takamizawa1, K. Kuroda1, R. Sugiyama1, K. Yamaguchi3
1Sugiyama Clinic Shinjuku, Center for Reproductive Medicine, Tokyo, Japan
2Chicago Medical School at Rosalind Franklin University of Medicine and Science, Reproductive Medicine- Department of Obstetrics and Gynecology, Chicago, U.S.A.
3National Center for Child Health and Development, Department of Maternal-Fetal Biology-, Tokyo, Japan
Couples’ perspectives on their need for treatment, support and follow-up after recurrent pregnancy loss
L. Schmidt1, E. Koert2, G.M.H. Malling1, R. Sylvest3, M.C. Krog2, A.M. Kolte2, H.S. Nielsen2
1University of Copenhagen, Department of Public Health- Section of Social Medicine, Copenhagen K, Denmark
2Copenhagen University Hospital- Rigshospitalet, Recurrent Pregnancy Loss Unit- Fertility Clinic, Copenhagen, Denmark
3Copenhagen University Hospital- Hvidovre, Dept. of Obstetrics and Gynaecology, Hvidovre, Denmark
11:00 O-257
11:15 O-258
11:30 O-259
FINAL PROGRAMME I BARCELONA, SPAIN – 1 TO 4 JULY 2018 169
SCIENTIFIC PROGRAMME WEDNESDAY, 4 JULY